More recently, 68 Ga-radiolabelled prostate-specific membrane antigen PET (PSMA-PET) demonstrated superiority over other imaging modalities and PET radiotracers in localizing primary staging and biochemical recurrent PCa [5–7]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.